First Trust NYSE Arca Biotechnology Index Fund (FBT) |
| 214.4 1.25 (0.59%) 01-13 15:59 |
| Open: | 214.42 |
| High: | 214.42 |
| Low: | 211.83 |
| Volume: | 16,941 |
| Market Cap: | 1,328(M) |
| PE Ratio: | 25.11 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 257.11 |
| Resistance 1: | 220.13 |
| Pivot price: | 212.89 |
| Support 1: | 210.79 |
| Support 2: | 205.02 |
| 52w High: | 220.14 |
| 52w Low: | 141.38 |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sun, 11 Jan 2026
(FBT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fri, 09 Jan 2026
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned - AOL.com
Fri, 09 Jan 2026
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned - 24/7 Wall St.
Thu, 01 Jan 2026
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
Wed, 31 Dec 2025
Responsive Playbooks and the FBT Inflection - Stock Traders Daily
Thu, 02 Oct 2025
The Best Biotech ETFs to Buy - Kiplinger
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
